Islândia -
islandês -
LYFJASTOFNUN (Icelandic Medicines Agency)
kåvepenin filmuhúðuð tafla 1 g
viatris aps - phenoxymethylpenicillinum kalíum - filmuhúðuð tafla - 1 g
Islândia -
islandês -
LYFJASTOFNUN (Icelandic Medicines Agency)
kåvepenin filmuhúðuð tafla 500 mg
viatris aps - phenoxymethylpenicillinum kalíum - filmuhúðuð tafla - 500 mg
Islândia -
islandês -
LYFJASTOFNUN (Icelandic Medicines Agency)
kåvepenin filmuhúðuð tafla 800 mg
viatris aps - phenoxymethylpenicillinum kalíum - filmuhúðuð tafla - 800 mg
Islândia -
islandês -
LYFJASTOFNUN (Icelandic Medicines Agency)
kåvepenin mixtúrukyrni, dreifa 100 mg/ml
viatris aps - phenoxymethylpenicillinum kalíum - mixtúrukyrni, dreifa - 100 mg/ml
Islândia -
islandês -
LYFJASTOFNUN (Icelandic Medicines Agency)
kåvepenin frukt (kåvepenin (mixt. 50 mg/ml)) mixtúrukyrni, dreifa 50 mg/ml
viatris aps - phenoxymethylpenicillinum kalíum - mixtúrukyrni, dreifa - 50 mg/ml
União Europeia -
islandês -
EMA (European Medicines Agency)
wakix
bioprojet pharma - pitolisant - narcolepsy - Önnur lyf í taugakerfinu - wakix is indicated in adults, adolescents and children from the age of 6 years for the treatment of narcolepsy with or without cataplexy (see also section 5.
União Europeia -
islandês -
EMA (European Medicines Agency)
sarclisa
sanofi winthrop industrie - isatuximab - mergæxli - Æxlishemjandi lyf - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.
Islândia -
islandês -
LYFJASTOFNUN (Icelandic Medicines Agency)
cloxacillin navamedic (cloxacillin villerton nordic a/s) stungulyfs-/innrennslisstofn, lausn 1 g
navamedic asa - cloxacillinum natríum - stungulyfs-/innrennslisstofn, lausn - 1 g
Islândia -
islandês -
LYFJASTOFNUN (Icelandic Medicines Agency)
cloxacillin vital pharma nordic stungulyfs-/innrennslisstofn, lausn 2 g
vital pharma nordic aps - cloxacillinum natríum - stungulyfs-/innrennslisstofn, lausn - 2 g
Islândia -
islandês -
LYFJASTOFNUN (Icelandic Medicines Agency)
doktacillin stungulyfs-/innrennslisstofn, lausn
viatris aps - ampicillinum natríum - stungulyfs-/innrennslisstofn, lausn